Anika Therapeutics (ANIK) Tmuɣli n wazal
Anika Therapeutics
Ṛṛbem n lḥedd$20.40Yettwalemmaḍ 25 Sep 2026 19:59 UTC
Beddel+0.54%
Asnulfu n AI: ANIK
AI tessawal ɣef timaqsiṭ n wazal i wass n tnekkit d-iteddun, taggara n yimal akked taggara n waggʷas. Asnifel yettwamḍen seg wazal aneggaru. Aya d tinineḍ n tḥisabt, ma tga ara timsisi n usihel.
Asref n 6 isggʷasn ineggura
Premium tessaɣ-d iswiyat n tɣara n AI i wass, amalas d waggʷas n yiwen i uḍris-a akk d yisɣunan niḍen.
Serreḥ Premium🔒 Tazmilt n usenfar
Amezruy n tmuɣliyin — akk tmuɣliyin n zik akked wazal n tnekkit — d akcum n Premium.
Serreḥ PremiumƔef tneɣlaft-a
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The company’s hyaluronic acid-based products promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika’s product portfolio includes ORTHOVISC and HYVISC, which are used to treat osteoarthritis.
